resveratrol has been researched along with Hypoglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YC; Chiang, MC; Lin, CH; Nicol, CJB; Wang, YS; Yen, C | 1 |
| Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL | 1 |
2 other study(ies) available for resveratrol and Hypoglycemia
| Article | Year |
|---|---|
Neuroprotective effects of resveratrol against oxygen glucose deprivation induced mitochondrial dysfunction by activation of AMPK in SH-SY5Y cells with 3D gelatin scaffold.
Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cell Survival; Gelatin; Humans; Hypoglycemia; Hypoxia; Mitochondria; Neuroprotective Agents; Resveratrol; Signal Transduction | 2020 |
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.
Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2014 |